PHARMADOC
LIVE
Serial Number
79215769
Owner
PLANET PHARMA SOLUTIONS, INC.Attorney
Charles T. J. WeigellFiling Date
Jun 23, 2017
PHARMADOC Trademark
Serial Number: 79215769 • Registration: 5461448
PHARMADOC is a trademark filed by
PLANET PHARMA SOLUTIONS, INC.
on June 23, 2017. The trademark is classified under Class 9 (Computers & Electronics).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Trademark Details
Filing Date
June 23, 2017
Registration Date
May 8, 2018
Published for Opposition
February 20, 2018
Goods & Services
Computer programs for processing word and data, and editing, preparing and managing documents
Filing History
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Dec 5, 2024 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Dec 5, 2024 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 2, 2024 APRE
TEAS SECTION 71 & 15 RECEIVED
Apr 26, 2024 ES75
NEW REPRESENTATIVE AT IB RECEIVED
May 21, 2020 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 15, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 21, 2018 FICS
FINAL DISPOSITION PROCESSED
Aug 21, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 8, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
May 8, 2018 R.PR
PUBLISHED FOR OPPOSITION
Feb 20, 2018 PUBO
NOTICE OF PUBLICATION
Jan 31, 2018 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 17, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 9, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 9, 2018 CRFA
ASSIGNED TO LIE
Jan 5, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 20, 2017 TROA
REFUSAL PROCESSED BY IB
Oct 13, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 26, 2017 RFCS
REFUSAL PROCESSED BY MPU
Sep 26, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 22, 2017 RFCR
NON-FINAL ACTION WRITTEN
Sep 21, 2017 CNRT
ASSIGNED TO EXAMINER
Sep 21, 2017 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 15, 2017 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 11, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 7, 2017 REPR
